SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024184
Filing Date
2022-11-10
Accepted
2022-11-10 08:15:26
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pepg-20221110.htm   iXBRL 8-K 54321
2 EX-99.1 pepg-ex99_1.htm EX-99.1 173172
3 GRAPHIC img148377401_0.jpg GRAPHIC 6751
  Complete submission text file 0000950170-22-024184.txt   364054

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pepg-20221110_lab.xml EX-101.LAB 13350
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pepg-20221110_pre.xml EX-101.PRE 9828
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pepg-20221110.xsd EX-101.SCH 2451
8 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20221110_htm.xml XML 4687
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 221375067
SIC: 2834 Pharmaceutical Preparations